CHECKPOINT INHIBITORS AND THEIR ASSOCIATION WITH VALVULAR DYSFUNCTION AMONG CANCER PATIENTS

Novel cancer therapies such as checkpoint inhibitors have improved the life expectancy of many cancer patients. However, they have also been associated with the development of myocarditis and (in rare cases) new onset heart failure. The purpose of this study was to determine if checkpoint inhibitor